Pharmaceuticals, Biotechnology and Life Sciences
Patients demonstrated statistically significant improvements in several hormonal and cardiometabolic parameters following treatment with DCCRREDWOOD CITY, Calif., June 13, 2022…
New data highlighting the potential of human islet cell transplantation for type 1 diabetes will be presentedSEATTLE, June 13, 2022…
SAN CARLOS, Calif., June 13, 2022 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel…
Leuven, BELGIUM, Boston, MA, US – JUNE 13, 2022 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next…
Eurobio Scientific expands into Benelux by acquiring the diagnostic company Biomedical Diagnostics NV Paris, June 13, 2022 –5:45 pm Eurobio…
PITTSBURGH, June 13, 2022 (GLOBE NEWSWIRE) — BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR…
Company hires Kassim Kolia, as Vice President, Business Development to grow cell and gene therapy businessStevenage ATMP site projected to…
Data show an overall response rate (ORR) of 64% and clinical benefit rate (CBR) of 91% in the first 22…
Investigational phase 3 data for Sogroya® (somapacitan) injection in children with growth hormone deficiency presented today at the ENDO 2022…
In final ELIANA analysis, 55% of patients with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL) who were treated…